Zum Hauptinhalt springen


Publications: (selected publications)

  1. Mattner J. Mohammed JP, Fusakio ME, Giessler C, Hackstein C-P, Opoka R, Wrage M, Schey R, Clark J, Fraser HI, Rainbow DB and Wicker LS. (2019). Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice. PLOSGenetics, in press
  2. Mattner J. and Wirtz S. (2017). Friend or foe? The ambiguous role of innate lymphoid cells in cancer development. Trends Immunol 38: 29-38
  3. Schey R, Dornhoff H, Baier JL, Purtak M, Opoka R, Koller AK, Atreya R, Rau TT, Daniel C, Amann K, Bogdan C and Mattner J. (2016). CD101 inhibits the expansion of colitogenic T cells. Mucosal Immunol 9: 1205-17
  4. Mattner J. (2013). Natural killer T (NKT) cells in autoimmune hepatitis. Curr Opin Immunol 25: 697-703
  5. Martin CE, Broecker F, Oberli MA, Komor J, Mattner J, Anish C and Seeberger PH. (2013). Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. JAm Chem Soc 135: 9713-9722
  6. Fusakio ME, Mohammed JP, Laumonnier Y, Hoebe K, Köhl J and Mattner J. (2011). C5a regulates NKT and NK cell functions in sepsis. J Immunol 187: 5805-12
  7. Mohammed JP, Fusakio ME, Rainbow DB, Moule C, Fraser HI, Clark J, Todd JA, Peterson LB, Savage PB, Wills-Karp M, Ridgway WM, Wicker LS and Mattner J. (2011). Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol 187: 337-49
  8. Rainbow DB, Moule C, Fraser HI, Clark J, Howlett SK, Burren O, Christensen M, Moody V, Steward CA, Mohammed JP, Fusakio ME, Masteller EL, Finger EB, Houchins JP, Naf D, Koentgen F, Ridgway WM, Todd JA, Bluestone JA, Peterson LB, Mattner J. and Wicker LS. (2011). Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice. J Immunol 187: 325-336
  9. Mattner J, Savage PB, Leung P, Oertelt SS, Wang V, Trivedi O, Scanlon ST, Pendem K, Teyton L, Hart J, Ridgway WM, Wicker LS, Gershwin ME and Bendelac A. (2008). Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3: 304-15
  10. Vas J, Mattner J, Richardson S, Ndonye R, Gaughan JP, Howell A and Monestier M. (2008). Regulatory roles for NKT cell ligands in environmentally-induced autoimmunity. J Immunol 181: 6779-6788
  11. Long X, Deng S, Mattner J, Zang Z, Zhou D, McNary N, Goff RD, Teyton L, Bendelac A and Savage PB. (2007). Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids. Nat Chem Biol 3: 559-564
  12. Zajonic DM, Cantu III C, Mattner J, Zhou D, Savage PB, Bendelac A, Wilson IA and Teyton L. (2005). Structure and function of a potent a-galactosylceramide agonist for the semi-invariant NKT cell receptor, Nat Immunol 6: 810-818
  13. Mattner J, Debord KL, Ismail N, Goff RD, Cantu III C, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB and Bendelac A. (2005). Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-9.
  14. Mattner J, Wandersee-Steinhauser A, Pahl A, Röllinghoff M, Majeau GR, Hochman PS and Bogdan C. (2004). Protection against progressive leishmaniasis by IFN-beta. J Immunol 172: 7574-82
  15. Bogdan C, Mattner J and Schleicher U. (2004) The role of type I interferons in non-viral infections. Immunological Reviews 202: 33-48

          further publications